Condition category
Oral Health
Date applied
06/03/2017
Date assigned
10/03/2017
Last edited
26/04/2017
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Background and study aims
Impacted mandibular third molar extraction (also known as wisdom teeth removal) is one of the most common operations in oral and maxillofacial (mouth and teeth) surgery. Wisdom teeth grow at the back of the mouth and are the last teeth that come up through the gums, usually when people are young adults. Due to a lack of space, wisdom teeth can come through the gums on an angle causing them to be impacted. This usually means they need to be removed surgically. The operation consists of a small cut into the gum, extracting (removing) the tooth and then stitching up the area where the tooth was. Usually, the wound heals within a week or two however patients can experience some pain and are at risk of developing dry socket (a dull ache in the gum or jaw and a bad smell or taste coming from the area the tooth was removed). In order to encourage healing, platelet rich fibrin (PRF) has been suggested to be used on the tooth removal area. PRF is collected from the patients’ blood and is then processed to separate out the platelets in order to be placed on the site where the tooth was removed. PRF is thought to help increase healing and reduce the possibility of complications. The aim of this study is to see how well PRF helps reduce edema (swelling) and pain after impacted mandibular third molars surgery.

Who can participate?
Adults aged 17-27 who require the removal of their impacted mandibular third molar.

What does the study involve?
Participants give a small sample of blood which is then processed in order to separate out the PRF. Participants then undergo the removal of their wisdom teeth in their lower jaw. Both of the lower wisdom teeth (right and left) are removed according to the standard level of care. However, the right side tooth removal area receives PRF (placed on the area with dental forceps (tool)) and the left side tooth removal area does not receive PRF. Both tooth removal areas are stitched up. Participants receive follow up for seven days after the procedure where they are tested for pain and edema.

What are the possible benefits and risks of participating?
Participants may benefit from a shorter recovery time. There are no notable risks with participating however participants may feel some discomfort when giving the blood sample.

Where is the study run from?
Ankara University Dentistry Faculty Oral and Maxillofacial Surgery Department (Turkey)

When is the study starting and how long is it expected to run for?
June 2011 to October 2013

Who is funding the study?
Investigator initiated and funded

Who is the main contact?
Dr Mehmet Fatih Şentürk
mehmetsenturk@sdu.edu.tr

Trial website

Contact information

Type

Scientific

Primary contact

Dr Mehmet Fatih Şentürk

ORCID ID

Contact details

Suleyman Demirel University
Dentistry Faculty
OMFS Dept.
Çünür
Isparta
06500
Turkey
+90 (0)536 333 0252
mehmetsenturk@sdu.edu.tr

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

N/A

Study information

Scientific title

Effect of platelet rich fibrin on edema and pain following third molar surgery: A split mouth control study

Acronym

Study hypothesis

The aim of this study is to evaluate the efficacy of platelet-rich fibrine (PRF) on postoperative edema and pain after impacted mandibular third molar surgery.

Ethics approval

Local Ethical Committee of the Ankara University Faculty of Dentistry, 28/11/2011, ref: 25/1

Study design

Prospective split-mouth randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Hospitals

Trial type

Quality of life

Patient information sheet

See additional files (in Turkish)

Condition

Bilateral impacted third molars

Intervention

Participants are selected based off their need for the removal of bilaterally (right-left) impacted mandibular third molars.

Prior to the procedure, participants have blood collected. After placing the collected blood in a centrifuge for 12 minutes to separate the different components, the platelet rich fibrin (PRF) is collected and prepared to be applied to the patient.

Participants then have both their left and right mandibular third molar extracted (done to the standard level of care). After extraction, participants receive PRF only to the right tooth extraction area. The left tooth extraction area does not receive anything. Both extraction sits are sutured. PRF is placed into the extraction area (tooth socket) using dental forceps.

Participants are followed up for seven days after the study. Follow up involves measurements of participants pain and edema of the extraction areas and takes place at the Ankara University Dentistry faculty Oral and Maxillofacial Surgery department. For standardisation reasons, all measurements are done by the same surgeon.

Intervention type

Procedure/Surgery

Phase

Drug names

Primary outcome measures

Pain is measured using a visual analogue scale (VAS) and Verbal rate scale (VRS) at 6 and 12 hours and 1, 2, 3 and 7 days after surgery.

Secondary outcome measures

Edema is measured using a flexible ruler at baseline, 2 and 7 days.

Overall trial start date

06/06/2011

Overall trial end date

19/10/2013

Reason abandoned

Eligibility

Participant inclusion criteria

1. Healthy patients without significant medical diseases or a history of bleeding problems
2. Symmetrical impacted third molars which feature the same level of surgical difficulty that require the same surgical technique to be performed
3. The third molars in the Class I, Level B position (according to Pell &Gregory) and in the vertical positions according to Winter
4. Aged 17–27 years

Participant type

Patient

Age group

Adult

Gender

Both

Target number of participants

30

Participant exclusion criteria

1. Pregnant and lactating women
2. Signs of pericoronitis
3. Chronic use of medications such as antihistamines, non-steroidal anti-inflammatory drugs (NSAID), steroids and antidepressants which would complicate the evaluation of their postoperative response

Recruitment start date

03/09/2012

Recruitment end date

01/05/2013

Locations

Countries of recruitment

Turkey

Trial participating centre

Ankara University Dentistry Faculty Oral and Maxillofacial Surgery Department
Emniyet Mahallesi
Ankara
06500
Turkey

Sponsor information

Organisation

Ankara University

Sponsor details

Dentistry Faculty
Oral and Maxillofacial Surgery Department
Besevler
Ankara
06500
Turkey
+90 (0)312 296 5576
fatih.senturk84@gmail.com

Sponsor type

Hospital/treatment centre

Website

dentistry.ankara.edu.tr

Funders

Funder type

Other

Funder name

Investigator initiated and funded

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Planned publication in a high-impact peer reviewed journal.

IPD Sharing plan:
The datasets generated during and/or analysed during the current study are/will be available upon request from Dr Uğur Gülşen (ugrgulsen@gmail.com)

Intention to publish date

31/12/2017

Participant level data

Available on request

Results - basic reporting

Publication summary

2017 results in: https://www.ncbi.nlm.nih.gov/pubmed/28438151

Publication citations

Additional files

Editorial Notes

26/04/2017: Publication reference added.